Martha Rook

Martha Rook

Chief Operating Officer bij DELCATH SYSTEMS, INC.

53 jaar
Health Technology
Commercial Services
Finance

Profiel

Martha S.
Rook
is currently the Chief Operating Officer at Delcath Systems, Inc. Prior to her current position, she held the role of Secretary & Director at Alliance for Regenerative Medicine.
From 2016 to 2018, she served as the VP, Head-Gene Editing & Novel Modalities at EMD Millipore Corp.
Martha then joined Sigilon Therapeutics, Inc. in 2018 as the Chief Technical Operations Officer until 2022.
She is currently also the Chief Technical Operations Officer at Insitro, Inc. Ms. Rook holds a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Texas A&M University.

Actieve functies van Martha Rook

BedrijvenFunctieBegin
DELCATH SYSTEMS, INC. Chief Operating Officer 18-03-2024
Alle actieve functies van Martha Rook

Eerdere bekende functies van Martha Rook

BedrijvenFunctieEinde
Chief Tech/Sci/R&D Officer 01-03-2024
SIGILON THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 07-03-2022
Corporate Officer/Principal 01-01-2018
Director/Board Member -
Ervaring van Martha Rook in detail bekijken

Opleiding van Martha Rook

Massachusetts Institute of Technology Doctorate Degree
Texas A&M University Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Martha Rook in detail bekijken

Connecties

73

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
DELCATH SYSTEMS, INC.

Health Technology

SIGILON THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit3

Commercial Services

Health Services

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Martha Rook